Clinical Trial Update: PSMAtrack-tracking Changes in PSMA-PET During Initial Therapy for Metastatic Hormone-sensitive Prostate Cancer [Phase 4]

View source ↗

Summary

Clinical trial update for a Phase 4 study (PSMAtrack) assessing PSMA-PET imaging changes during initial therapy for metastatic hormone-sensitive prostate cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-sensitive Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Metastatic Prostate Cancer, Hormone Sensitive Prostate Cancer | Phase 4 | Status: ACTIVE_NOT_RECRUITING